Tamara L Kalir - Anatomic Pathology and Clinical Pathology

Biography

Specialties

Anatomic Pathology and Clinical Pathology

Research

Our main research interest is the pathogenesis of ovarian cancer. Studies ranged from morphologic and immunohistochemical comparisons of endometriosis with atypical endometriosis and associated neoplasia, to investigating the nuclear membrane pore complex in ovarian cancer, via electron microscopic and molecular biologic techniques. These exciting studies are ongoing and students are encouraged to participate.

Education

PhD, Georgetown University

MD, University of California School of Medicine

MD, University of California San Diego

Mount Sinai School of Medicine

Residency, Pathology, Mount Sinai Hospital

Fellowship, Pathology Gynecologic, Mount Sinai Hospital

Publications

77

Publications

Selected Publications

Gynecologic manifestations of Peutz-Jeghers syndrome. Swati Bhardwaj, Tamara Kalir. International Journal of Gynecological Cancer

Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient. Katherine Reid, Olga Camacho-Vanegas, Deep Pandya, Sandra Catalina Camacho, Rui Fang Qiao, Tamara Kalir, Maria M. Padron-Rhenals, Ann Marie Beddoe, Peter Dottino, John A. Martignetti. Cold Spring Harbor molecular case studies

High-grade pelvic-type serous carcinoma presenting as a breast rash. Mark Weingarten, Michael Weingarten, Tamara Kalir, Angela Lamb. JAAD Case Reports

View All Publications

Office Locations

Annenberg Building Floor 15 Floor Room Swing Room

1468 Madison Ave

New York, NY 10029

212-241-3784

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Kalir has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Kalir has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.